Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

Daiichi Sankyo has made a little bit of pharma industry ... that direct injection into the tumour is well tolerated with no severe adverse effects. Efficacy data will come later, along with ...

For years, social media users have shared what they describe as Netflix's original logo featuring black lettering and a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

8316.T Sumitomo Mitsui Financial Group, Inc.

A Singapore court on Monday found opposition party leader Pritam Singh guilty on two counts of lying to parliament, handing down fines that spared him a loss of his seat and a ban from this year's ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...